{"name":"PreCision Dermatology, Inc.","slug":"precision-dermatology-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PDI-192","genericName":"PDI-192","slug":"pdi-192","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"PDI-192","genericName":"PDI-192","slug":"pdi-192","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOTjRIak9uUlJtX0VqeURGSkU0MUVxYXIzODAwSm9HSWZ2NlZZX3ZqWnM2X3BpZEgxOGg1ZVd3d3VneEdHcmctUXYycDhvTVlYY3k2Z3FNcXVQdDdPZ1hMWENnTUg5MFNxUFFreHJ5dC1JT056WTRPaVNrZzZuNmdSUHRQRGdoZl9TNGJVODZHbUNlak9VS2c?oc=5","date":"2026-03-18","type":"pipeline","source":"Yahoo Finance","summary":"Mindera Health™ and Mountaineer Biosciences Launch Subtilitas, a Precision Translational Medicine Platform for Dermatology and Immunology - Yahoo Finance","headline":"Mindera Health™ and Mountaineer Biosciences Launch Subtilitas, a Precision Translational Medicine Platform for Dermatolo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxOQ21wUENucGNRT0p5Ml80eHZvUnVoOERSd3FJWFRLUDVLTnFoUm1lLUU0WEE5czBnS19LNnYxNW1VUUJtNVdDUURiaWhNZlQ5a1JBQklGc09FZ3dTeDBhdng1aU0ycnkyaWFJSkVxRVVJVXNzR3cwSjBVRjMtWkpUQjZUU3hoZjYwYUR0aVJlbTdMMHVOcVVFQ1RFZUJaZlpUWEZfUEVkamp6U21yOV9aV0x1OW45Y0ZkbG13R1FOWVZmUzBRemY0bXdyNUpMZk9SVHh6a2dVMlJyMGxRU1ZpNElnMXpWTU56dlA0VUs3QzVVR2cwM2dEYkFBV2JMTXJZbmc?oc=5","date":"2026-03-13","type":"pipeline","source":"prnewswire.com","summary":"Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement - prnewswire.com","headline":"Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPSWQ2STNxWWROQ2M3RVFISU5wR2VCUFlKSGx1RThuR3BTNU43QW1rLURVa0FrcGRneVZPdkJyUUY4SFBoWndSRmpXWnBXUldyQkh2U3Vpa0kwUEYzV1VNMElIXzdYeXptVFYwUUtUajEtWDVkYXRSWFJVeU9OZ1d0Zm8zUjhBY0EyeVkydXpkSGVpNTA3LTRSRkxjbkNaUjQ4bVdmUVpyYnRIWXVhWlhKbzliT01VYnRkak13Y0FCYzF5eDBVSGRUUQ?oc=5","date":"2026-03-05","type":"pipeline","source":"prnewswire.com","summary":"Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders - prnewswire.com","headline":"Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPWTMtSHY4emdiSEpyUDdCZE1KMUZnM2F5dXFfcTUtcjVsSnVkT25IQUhXaG40OTBoMHhuMlVlNy1GcmxMRHlxMkdINVF3LUFpNTFESURpNUNCVDN1cTk2UWZUSDRzbEtkdm9aZDZRZmlQanJ2OWQweFpCOVZJOHZIX2g2SE1lejFRQUNBYkZSM2stWlNyNEY0Y0duaXhLVExYRU1QcDZvNGZLeER3R1dDWVZEUF84RDVqUVdTcGZ2eHhjVVVqSmQyUA?oc=5","date":"2026-02-27","type":"pipeline","source":"prnewswire.com","summary":"Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates - prnewswire.com","headline":"Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOY1VBZXQwcFJfS3NwTXVwTnZoQzVlNGxVTFo0d3ZzM0RLbVNDTXk1Vzd4SHhIS1A0SkFxQVNnbHR4Y1pFY0FjcWpzMXRuY1lCYlhNM2ktQ3phVzJfdGdXTlN2SmpmTnJDMnotdkItS1d2WE1ENEpQank2c18xQ2RtS2xXQWwtZ1k1bl85Y0hVZ2g4dw?oc=5","date":"2026-02-27","type":"pipeline","source":"TradingView","summary":"Azitra, Inc. SEC 10-K Report - TradingView","headline":"Azitra, Inc. SEC 10-K Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQMUo0dnVJRXl1bGVNdVpHX2d2QWhnbW5GWktHMExNSjBnc2J2ejM1SUc1WXowSm43QXN2ajh3WXNKUUxUS2pkTm44M0RJamdUekk3bjV3ZmhqZVJZUGhhQ1BOcGFxaFJjU1hVa0xQMjl0bVZBYzN1LWhoSFJzT05WOVRBeHZBVFAyRFJGc2wxbFF0dzBVdXc1bUN3TXdIUHhx?oc=5","date":"2026-02-27","type":"pipeline","source":"Stock Titan","summary":"Azitra (NYSE American: AZTR) widens 2025 loss while pushing key skin programs - Stock Titan","headline":"Azitra (NYSE American: AZTR) widens 2025 loss while pushing key skin programs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQU1ctU0VncGxvZ3l5bnJpemhiZjhQUks1RkNoWFEwb18xR0JvWUNya3JpRHpVV0VFaHllTmxEWFhjM1BMT1hKdVdPcTZTaVc2YVVoenA1YXNWUHdUbnRKZXBxelJhYm4xRjZiUUdwcEJqV0JVN25YZUtkMk1pVGJJVUo4SzBRd3FZWGVjSTNFajVmTDRoblY2Z1NBSVhYZDhYbDRjZW1GeklLdHNFdkRIdTBnczFfbjFS?oc=5","date":"2026-02-07","type":"regulatory","source":"lupin.com","summary":"Lupin receives FDA approval for generic Hydrocortisone Butyrate Lotion, 0.1% - Lupin | Press Release - lupin.com","headline":"Lupin receives FDA approval for generic Hydrocortisone Butyrate Lotion, 0.1% - Lupin | Press Release","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5mYWpBQ19UY2xhNHJJTHRlT1FfZE5mSDJIN3FhZkY0NU5pRHBhR0xjazR1Z2UzQWlmYlVKX1JXN0ZvQ08wOEtPQzVLNEVqUHBEVTYzdUZuSW5CUnVWT18yRHhBcU15b0J6emlGNA?oc=5","date":"2026-01-01","type":"pipeline","source":"Dermatology Times","summary":"Drugs to Watch in 2026 - Dermatology Times","headline":"Drugs to Watch in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQOUgyWkJkRGtoV1ZRSWxiS1dHOGlWYWd0YTB4bmE5NHpTdWZTMkJIR0VpRDJBWjBYYlFycnBLSk1qbHZ3VGVkRi0zU0kwZHdVbTRPRUNPbFN1MlZmVEwtXzU2dFhQMlNLVW01YVhjY01UcXdyRUdhOWVvc3J6WFlCVjRKR0c2dlpJNWxRWThRbFpNZTg5UUk2VnhZQ3FjX1hGMFlHaU5idzJQUXRYNkE?oc=5","date":"2025-11-13","type":"deal","source":"BioSpace","summary":"Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK® - BioSpace","headline":"Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTFBHdUNfeFEyelQtOUtjTW00S2o5TGIxTjg2dVVGc0RTVU9jejg0STFtaTNzM0FNTkxwWThydGdnZXFsbVVEWWZmcTVUQ0RlY3VQRU5Bd3o2S2k0dWl5dUd2a2tBNENnNjVoUC00?oc=5","date":"2025-09-08","type":"pipeline","source":"Straits Research","summary":"Atopic Dermatitis Market Size, Share, Players & Trends by 2034 - Straits Research","headline":"Atopic Dermatitis Market Size, Share, Players & Trends by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNbUd4bThxcXlHOHU2ODBIVXV3QW40WUFpUDA3M2xlZzl3bUdoWkV6TlFKSFZCbzA2Q3h0aTdmWllJaDZCcHN3VlZ3cFA2Q0JWZVFHWlVNUElOdkJyUDE3clJiMkd6MnhQRjM4RDF0VzRZcE5lS3dSRDh2T1hKMko3d3R2akl5Q1p1OGxhUGFlU1dDZW5MQ3BQWFBFTDJlVkJmX3ZqNTB5REhkZ2x1OHFsQ01Ed1Y4RlVfX0kwaGpjaGVac2FBTTJrOA?oc=5","date":"2025-08-29","type":"pipeline","source":"GlobeNewswire","summary":"Dermatology Market to Worth USD 2.75 Billion Size by 2034 - GlobeNewswire","headline":"Dermatology Market to Worth USD 2.75 Billion Size by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFBxUFJiY1F5SjFjaF9SVnEwTlUwbHFPTFVWWWRmV0ktZDFFa2xLNUlIcHpydDMzRFdkNWtXWnB6S1NGS2pMLU5MeWpyZ2xuQmwxY3NVZVlHSHZaaEhKZ1RERURNVHBBM0ptSHNXaQ?oc=5","date":"2025-06-17","type":"pipeline","source":"Market.us","summary":"Dermatological Drugs Market Size, Share | CAGR Of 10.4% - Market.us","headline":"Dermatological Drugs Market Size, Share | CAGR Of 10.4%","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}